Fibrobiologics Common Stock Stock Price Patterns
| FBLG Stock | 0.27 0.02 8.00% |
Momentum 58
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.1) | EPS Estimate Current Year (0.48) | EPS Estimate Next Year (0.41) | Wall Street Target Price 7 | EPS Estimate Current Quarter (0.12) |
Using FibroBiologics Common hype-based prediction, you can estimate the value of FibroBiologics Common Stock from the perspective of FibroBiologics Common response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in FibroBiologics Common to buy its stock at a price that has no basis in reality. In that case, they are not buying FibroBiologics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
FibroBiologics Common after-hype prediction price | USD 0.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
FibroBiologics | Build AI portfolio with FibroBiologics Stock |
FibroBiologics Common After-Hype Price Density Analysis
As far as predicting the price of FibroBiologics Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in FibroBiologics Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of FibroBiologics Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
FibroBiologics Common Estimiated After-Hype Price Volatility
In the context of predicting FibroBiologics Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on FibroBiologics Common's historical news coverage. FibroBiologics Common's after-hype downside and upside margins for the prediction period are 0.01 and 9.70, respectively. We have considered FibroBiologics Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
FibroBiologics Common is extremely dangerous at this time. Analysis and calculation of next after-hype price of FibroBiologics Common is based on 3 months time horizon.
FibroBiologics Common Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as FibroBiologics Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading FibroBiologics Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with FibroBiologics Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 9.43 | 0.00 | 0.02 | 10 Events / Month | 6 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.27 | 0.27 | 0.00 |
|
FibroBiologics Common Hype Timeline
FibroBiologics Common is currently traded for 0.27. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. FibroBiologics is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.07%. %. The volatility of related hype on FibroBiologics Common is about 3122.52%, with the expected price after the next announcement by competition of 0.25. About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.48. FibroBiologics Common had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out FibroBiologics Common Basic Forecasting Models to cross-verify your projections.FibroBiologics Common Related Hype Analysis
Having access to credible news sources related to FibroBiologics Common's direct competition is more important than ever and may enhance your ability to predict FibroBiologics Common's future price movements. Getting to know how FibroBiologics Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how FibroBiologics Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DARE | Dare Bioscience | 0.06 | 8 per month | 0.00 | (0.03) | 6.55 | (6.98) | 26.52 | |
| ATHA | Athira Pharma | (0.54) | 9 per month | 4.10 | 0.05 | 6.70 | (8.06) | 71.83 | |
| ADTX | Aditxt Inc | (0.80) | 8 per month | 0.00 | (0.16) | 22.54 | (26.05) | 63.67 | |
| AIMD | Ainos Inc | 0.06 | 9 per month | 0.00 | (0.11) | 12.30 | (10.43) | 38.73 | |
| CTXR | Citius Pharmaceuticals | (0.15) | 6 per month | 0.00 | (0.11) | 10.59 | (9.01) | 38.23 | |
| MBRX | Moleculin Biotech | (0.84) | 10 per month | 0.00 | (0.21) | 9.37 | (11.73) | 41.63 | |
| LPTX | Leap Therapeutics | 0.01 | 9 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| APLM | Apollomics Class A | (0.72) | 2 per month | 6.27 | 0.11 | 17.08 | (11.40) | 44.38 | |
| ICU | SeaStar Medical Holding | (0.07) | 9 per month | 0.00 | (0.14) | 9.58 | (9.88) | 34.66 | |
| HOTH | Hoth Therapeutics | (0.03) | 7 per month | 0.00 | (0.14) | 5.83 | (5.79) | 13.69 |
FibroBiologics Common Additional Predictive Modules
Most predictive techniques to examine FibroBiologics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for FibroBiologics using various technical indicators. When you analyze FibroBiologics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About FibroBiologics Common Predictive Indicators
The successful prediction of FibroBiologics Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as FibroBiologics Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of FibroBiologics Common based on analysis of FibroBiologics Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to FibroBiologics Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to FibroBiologics Common's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for FibroBiologics Stock analysis
When running FibroBiologics Common's price analysis, check to measure FibroBiologics Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroBiologics Common is operating at the current time. Most of FibroBiologics Common's value examination focuses on studying past and present price action to predict the probability of FibroBiologics Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroBiologics Common's price. Additionally, you may evaluate how the addition of FibroBiologics Common to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |